Home/Filings/4/0001104659-23-120375
4//SEC Filing

Martins Eduardo Bruno 4

Accession 0001104659-23-120375

CIK 0001400118other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 4:23 PM ET

Size

5.1 KB

Accession

0001104659-23-120375

Insider Transaction Report

Form 4
Period: 2023-11-17
Martins Eduardo Bruno
Chief Medical Officer
Transactions
  • Award

    Series A Common Stock

    2023-11-17+89,57089,570 total
Footnotes (1)
  • [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. 25% of the RSUs shall vest on July 18, 2024, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Issuer

Sagimet Biosciences Inc.

CIK 0001400118

Entity typeother

Related Parties

1
  • filerCIK 0001670431

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 4:23 PM ET
Size
5.1 KB